29 is the total number of securities Saturn V Capital Management LP has owned. The longest Saturn V Capital Management LP has owned a single stock is 4 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| CRNX | CRINETICS PHARMACEUTIC... | 4 | 4 | 8.89% | 10.42% | 14.02% | Q4 2022 | Q3 2023 | 4 |
| CBAY | CYMABAY THERAPEUTICS INC | 4 | 4 | 4.74% | 7.40% | 10.61% | Q4 2022 | Q3 2023 | 4 |
| CYTK | CYTOKINETICS INC | 4 | 4 | 6.11% | 6.88% | 7.44% | Q4 2022 | Q3 2023 | 4 |
| KALV | KALVISTA PHARMACEUTICA... | 4 | 4 | 5.56% | 6.62% | 7.30% | Q4 2022 | Q3 2023 | 4 |
| HZNP | HORIZON THERAPEUTICS P... | 4 | 4 | 4.71% | 5.96% | 8.09% | Q4 2022 | Q3 2023 | 4 |
| BIIB | BIOGEN INC(NSM) | 4 | 4 | 1.80% | 5.76% | 7.78% | Q4 2022 | Q3 2023 | 4 |
| ASND | ASCENDIS PHARMA A/S - ADR | 4 | 4 | 3.88% | 5.27% | 6.60% | Q4 2022 | Q3 2023 | 4 |
| ITOS | ITEOS THERAPEUTICS INC | 4 | 4 | 4.56% | 4.99% | 5.83% | Q4 2022 | Q3 2023 | 4 |
| MORF | MORPHIC HOLDING INC | 4 | 4 | 1.31% | 4.80% | 6.93% | Q4 2022 | Q3 2023 | 4 |
| BCRX | BIOCRYST PHARMACEUTICA... | 4 | 4 | 2.91% | 4.25% | 7.25% | Q4 2022 | Q3 2023 | 4 |
| ASTRIA THERAPEUTICS INC | 4 | 4 | 1.01% | 2.26% | 3.81% | Q4 2022 | Q3 2023 | 4 | |
| KDNY | CHINOOK THERAPEUTICS INC | 3 | 3 | 5.58% | 8.51% | 11.18% | Q4 2022 | Q2 2023 | 3 |
| APLS | APELLIS PHARMACEUTICAL... | 3 | 3 | 5.43% | 6.44% | 7.81% | Q4 2022 | Q2 2023 | 3 |
| SAGE | SAGE THERAPEUTICS INC | 3 | 3 | 1.84% | 3.61% | 4.54% | Q4 2022 | Q2 2023 | 3 |
| COGT | COGENT BIOSCIENCES INC | 2 | 2 | 7.24% | 7.38% | 7.51% | Q2 2023 | Q3 2023 | 2 |
| 2SEVENTY BIO INC | 2 | 2 | 1.31% | 4.76% | 8.20% | Q4 2022 | Q1 2023 | 2 | |
| SRPT | SAREPTA THERAPEUTICS INC | 2 | 2 | 3.43% | 4.72% | 6.01% | Q2 2023 | Q3 2023 | 2 |
| ARQT | ARCUTIS BIOTHERAPEUTIC... | 2 | 2 | 1.46% | 4.38% | 7.29% | Q4 2022 | Q1 2023 | 2 |
| BMRN | BIOMARIN PHARMACEUTICA... | 2 | 2 | 4.06% | 4.26% | 4.45% | Q2 2023 | Q3 2023 | 2 |
| SNDX | SYNDAX PHARMACEUTICALS... | 2 | 2 | 2.02% | 3.46% | 4.91% | Q2 2023 | Q3 2023 | 2 |
| FOLD | AMICUS THERAPEUTICS IN... | 2 | 2 | 2.14% | 3.10% | 4.06% | Q4 2022 | Q1 2023 | 2 |
| ARGX | ARGENX SE | 2 | 2 | 0.88% | 1.48% | 2.07% | Q2 2023 | Q3 2023 | 2 |
| SCILEX HOLDING CO(NAS) | 2 | 2 | 0.03% | 0.05% | 0.06% | Q1 2023 | Q2 2023 | 2 | |
| AMYLYX PHARMACEUTICALS... | 1 | 1 | 6.79% | 6.79% | 6.79% | Q3 2023 | Q3 2023 | 1 | |
| ALBO | ALBIREO PHARMA INC | 1 | 1 | 5.70% | 5.70% | 5.70% | Q4 2022 | Q4 2022 | 1 |
| ANAB | ANAPTYSBIO INC | 1 | 1 | 4.34% | 4.34% | 4.34% | Q3 2023 | Q3 2023 | 1 |
| TBPH | THERAVANCE BIOPHARMA INC | 1 | 1 | 1.11% | 1.11% | 1.11% | Q4 2022 | Q4 2022 | 1 |
| JASPER THERAPEUTICS INC | 1 | 1 | 0.41% | 0.41% | 0.41% | Q3 2023 | Q3 2023 | 1 | |
| MRUS | MERUS N V | 1 | 1 | 0.40% | 0.40% | 0.40% | Q3 2023 | Q3 2023 | 1 |
Download | |||||||||
The securities at the top of the list , including CRINETICS PHARMACEUTICALS IN, CYMABAY THERAPEUTICS INC, and CYTOKINETICS INC, are the highest-conviction holdings of Saturn V Capital Management LP.
The conviction is calculated by counting the number of quarters a security has been reported by Saturn V Capital Management LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Saturn V Capital Management LP owns currently or has owned in the past.